Equities

Sawai Group Holdings Co Ltd

Sawai Group Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,970.00
  • Today's Change10.00 / 0.25%
  • Shares traded72.10k
  • 1 Year change-8.21%
  • Beta0.7699
Data delayed at least 20 minutes, as of Jan 27 2023 06:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

  • Revenue in JPY (TTM)192.93bn
  • Net income in JPY-31.03bn
  • Incorporated2021
  • Employees2.97k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shin Nippon Biomedical Laboratories Ltd20.14bn8.04bn94.88bn994.0011.803.8110.074.71193.21193.21483.67597.850.42991.626.7320,257,290.0017.215.0625.227.6553.5045.4840.0314.970.9142--0.423124.1317.460.577894.65--9.71--
TOWA PHARMACEUTICAL CO., LTD173.86bn9.36bn104.27bn4.08k10.850.71814.460.5997186.62186.623,473.482,818.590.57521.453.6842,633,890.003.105.904.337.8439.1044.125.3910.220.8056--0.51816.486.9214.2814.0123.34-8.5012.47
KYORIN Holdings, Inc.105.53bn5.05bn110.35bn2.22k19.370.784712.481.0588.1888.181,841.562,176.730.6211.303.0447,491,000.002.973.333.664.0346.1351.064.795.461.87--0.144370.592.56-1.77-35.86-11.650.338-2.16
Zeria Pharmaceutical Co Ltd64.64bn5.84bn114.47bn1.74k16.421.5410.031.77131.27131.271,450.171,395.010.50091.463.7937,213,090.004.543.107.274.9871.6971.289.075.920.74556.650.466545.8712.84-1.7026.032.25-17.521.81
Kissei Pharmaceutical Co Ltd65.86bn10.58bn132.12bn1.83k11.110.58779.022.01229.45229.451,428.104,338.620.27181.753.0036,026,800.004.413.164.793.4248.5355.9816.2310.454.82--0.007934.12-5.31-1.83144.4810.83-5.394.01
Mochida Pharmaceutical Co Ltd109.37bn9.58bn137.35bn1.54k13.530.98711.231.26252.77252.772,899.753,464.880.6782.243.5870,835,500.005.945.227.126.4053.9951.578.757.763.62--0.0040.566.982.5123.084.3921.993.04
KAKEN PHARMACEUTICAL CO., LTD.75.27bn8.79bn173.42bn1.16k16.191.0115.362.30233.13233.131,994.153,730.820.45222.063.6564,660,650.005.2810.156.0312.0654.4356.0911.6818.285.04--0.026737.001.41-5.61-28.77-15.396.710.00
Sawai Group Holdings Co Ltd192.93bn-31.03bn173.85bn2.97k--0.8596--0.9011-709.06-709.064,400.234,618.620.49431.482.8865,002,360.00-11.391.25-15.971.7031.7638.97-23.052.461.24-155.680.258576.823.527.92-329.08--4.380.00
Sosei Group Corporation22.76bn-383.00m199.81bn198.00--3.59213.938.78-4.70-4.70278.03679.920.2473--19.92114,964,600.00-0.416---0.4321--95.45---1.68----2.570.3475--100.32---31.24------
TAKARA BIO INC.68.74bn18.38bn208.32bn1.67k11.341.959.133.03152.62152.62570.82886.080.61151.214.5941,257,500.0016.399.9418.7911.1669.4665.3726.8118.174.3137.630.0021.0346.9018.17107.9171.1452.5752.51
Tsumura & Co136.24bn20.76bn211.62bn3.92k10.160.81886.741.55271.40271.401,781.063,367.090.36880.72032.4734,745,470.005.835.197.066.2850.3455.7815.8012.783.66--0.222631.4511.282.4222.858.574.990.00
JCR Pharmaceuticals Co Ltd38.28bn6.24bn211.65bn816.0032.524.0225.715.5350.1950.19308.22405.710.4350.70082.4946,911,760.007.1111.4711.7016.2771.7673.5816.3420.621.17--0.262422.4669.7923.08110.4950.7548.8629.46
Data as of Jan 27 2023. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

26.21%Per cent of shares held by top holders
HolderShares% Held
Silchester International Investors LLPas of 09 Aug 20224.04m9.23%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Nov 20221.47m3.36%
Nomura Asset Management Co., Ltd.as of 30 Dec 20221.38m3.15%
The Vanguard Group, Inc.as of 05 Jan 20231.10m2.52%
Nikko Asset Management Co., Ltd.as of 30 Nov 2022725.00k1.66%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2022623.00k1.42%
Dimensional Fund Advisors LPas of 05 Jan 2023613.12k1.40%
Norges Bank Investment Managementas of 31 Dec 2021612.94k1.40%
Baillie Gifford & Co.as of 19 Jan 2023483.80k1.11%
BlackRock Fund Advisorsas of 05 Jan 2023422.80k0.97%
More ▼
Data from 31 Dec 2021 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.